BioArctic AB's (publ) (NASDAQ Stockholm: BIOA B) partner Eisai announced today that the application for manufacturing and marketing approval for lecanemab ...
LAGUNA HILLS, CA / ACCESSWIRE / January 29, 2023 / BrainChip Holdings Ltd (ASX:BRN)(OTCQX:BRCHF)(ADR:BCHPY), the world's first commercial producer of ultra-low power, fully digital, event-based, neuro ...
WINNIPEG, MB / ACCESSWIRE / January 29, 2023 / Snow Lake Resources Ltd., d/b/a/ Snow Lake Lithium Ltd. (NASDAQ:LITM) ("Snow Lake" or the "Company") is pleased to provide a strategic update from the Ch ...
The Royal College of Surgeons in Ireland - Medical University of Bahrain (RCSI Bahrain) has announced receiving accreditation for its nursing ...
Year-over-year revenue grows 16%, operating profit up 13%, non-GAAP operating profit up 14% Note: A webcast of ResMed's conference call will be available at 4:30 p.m. ET today at ...
HOLLAND, Mich., Jan. 26, 2023 (GLOBE NEWSWIRE) -- Macatawa Bank Corporation (NASDAQ: MCBC), the holding company for Macatawa Bank (collectively, the "Company"), today announced its results for the ...
Kirby Corporation (NYSE: KEX) ("Kirby" or "the Company") today announced the appointment of Susan W. Dio to the Company's Board, effective January 24, 2023.
LOS ANGELES, Jan. 26, 2023 (GLOBE NEWSWIRE) -- PacWest Bancorp (Nasdaq: PACW) - FOURTH QUARTER 2022 RESULTS $39.6M$0.3314.39%8.70%Net Earnings Available to Common StockholdersDiluted Earnings per ...
INDIANA, Pa., Jan. 24, 2023 (GLOBE NEWSWIRE) -- First Commonwealth Financial Corporation (NYSE: FCF) today announced financial results for the fourth quarter and full year of 2022. Financial Summary ...
HARRISBURG, Pa., Jan. 25, 2023 (GLOBE NEWSWIRE) -- Mid Penn Bancorp, Inc. (NASDAQ: MPB) ("Mid Penn"), the parent company of Mid Penn Bank (the "Bank") and MPB Financial Services, LLC, today reported ...
PRNewswire/ -- "In 2022, the Volvo Group delivered strong growth as well as good profitability and cash flow. For the full year, we increased net sales by over SEK ...
Genelux Corporation ("Genelux" or "the Company"), a clinical-stage immunotherapy company focused on developing a pipeline of next-generation ...